|
INTS12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25130000028228E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.88500000000347E-05 |
| Normal-vs-Stage2 |
4.1763000000028E-05 |
| Normal-vs-Stage3 |
1.56370000281569E-08 |
| Normal-vs-Stage4 |
9.94050000091562E-08 |
| Stage1-vs-Stage2 |
1.491580E-01 |
| Stage1-vs-Stage3 |
7.976300E-03 |
| Stage1-vs-Stage4 |
1.196200E-02 |
| Stage2-vs-Stage3 |
6.657200E-01 |
| Stage2-vs-Stage4 |
4.560600E-01 |
| Stage3-vs-Stage4 |
6.387000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96020000015262E-07 |
| Normal-vs-AfricanAmerican |
1.99260000000034E-06 |
| Normal-vs-Asian |
6.099700E-03 |
| Caucasian-vs-AfricanAmerican |
1.036650E-01 |
| Caucasian-vs-Asian |
1.075560E-01 |
| AfricanAmerican-vs-Asian |
7.279900E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15289999991219E-07 |
| Normal-vs-Female |
7.64309999956581E-07 |
| Male-vs-Female |
3.133600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.202700000002E-05 |
| Normal-vs-Age(41-60Yrs) |
2.46319999996913E-06 |
| Normal-vs-Age(61-80Yrs) |
3.97350041758671E-10 |
| Normal-vs-Age(81-100Yrs) |
1.517330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.974200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.244480E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.215800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097530E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.501800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.912800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.877410E-01 |
| Classical-VS-Follicular |
7.677600E-03 |
| Classical-VS-Other |
3.622400E-01 |
| Classical-VS-Normal |
1.67369999999334E-05 |
| Tall-VS-Follicular |
7.061200E-01 |
| Tall-VS-Other |
8.289200E-01 |
| Tall-VS-Normal |
6.18669999999932E-05 |
| Follicular-VS-Other |
9.985800E-01 |
| Follicular-VS-Normal |
1.44819999992052E-07 |
| Other-VS-Normal |
9.983000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.94000000011785E-07 |
| Normal-vs-N1 |
3.07600000004626E-06 |
| N0-vs-N1 |
5.413800E-01 |
|
|
